Launch of LAIV Flu vaccine in China
Melbourne, 25 August 2020: Australian vaccine development company BioDiem Ltd is pleased to announce the product launch of Changchun BCHT Biotechnology Co (BCHT)’s LAIV vaccine in China. This is a major milestone for BCHT and for BioDiem. BCHT is BioDiem’s licencee for the LAIV flu vaccine technology in China.
